| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Antiphospholipid Syndrome | 4 | 2019 | 533 | 1.09 | Why? |
| Adiposity | 3 | 2022 | 329 | 0.94 | Why? |
| Nervous System Autoimmune Disease, Experimental | 1 | 2018 | 1 | 0.77 | Why? |
| Intra-Abdominal Fat | 1 | 2021 | 227 | 0.73 | Why? |
| Toll-Like Receptor 7 | 2 | 2021 | 402 | 0.72 | Why? |
| Phosphatidylserines | 1 | 2018 | 99 | 0.72 | Why? |
| Toll-Like Receptor 8 | 1 | 2018 | 102 | 0.70 | Why? |
| Peritoneum | 1 | 2017 | 54 | 0.70 | Why? |
| Prothrombin | 1 | 2018 | 149 | 0.70 | Why? |
| Peritoneal Diseases | 1 | 2017 | 24 | 0.69 | Why? |
| Immune System Diseases | 2 | 2021 | 410 | 0.66 | Why? |
| Fetal Growth Retardation | 1 | 2018 | 217 | 0.61 | Why? |
| Serum Amyloid P-Component | 1 | 2017 | 193 | 0.61 | Why? |
| Myositis | 1 | 2018 | 185 | 0.58 | Why? |
| Malnutrition | 2 | 2020 | 932 | 0.54 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.52 | Why? |
| Imidazoles | 1 | 2018 | 631 | 0.49 | Why? |
| Pre-Eclampsia | 1 | 2018 | 599 | 0.46 | Why? |
| Inflammation | 9 | 2021 | 13255 | 0.43 | Why? |
| Leukocytes | 1 | 2017 | 1046 | 0.42 | Why? |
| Autoantibodies | 3 | 2018 | 2094 | 0.42 | Why? |
| Hypocalcemia | 2 | 2020 | 120 | 0.38 | Why? |
| Cognitive Dysfunction | 1 | 2020 | 1389 | 0.37 | Why? |
| C-Reactive Protein | 5 | 2020 | 7972 | 0.37 | Why? |
| Radiography, Thoracic | 3 | 2021 | 5486 | 0.35 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.33 | Why? |
| Phagocytosis | 2 | 2018 | 409 | 0.30 | Why? |
| Extracellular Traps | 3 | 2021 | 1036 | 0.30 | Why? |
| Antibodies, Monoclonal, Humanized | 4 | 2021 | 9335 | 0.30 | Why? |
| Testosterone | 2 | 2021 | 596 | 0.30 | Why? |
| Survivors | 4 | 2021 | 2619 | 0.29 | Why? |
| Antibodies, Antiphospholipid | 3 | 2019 | 519 | 0.29 | Why? |
| Stress Disorders, Post-Traumatic | 2 | 2020 | 2963 | 0.28 | Why? |
| Acute Coronary Syndrome | 1 | 2018 | 2107 | 0.28 | Why? |
| HMGB1 Protein | 3 | 2018 | 223 | 0.26 | Why? |
| Calcium | 2 | 2020 | 708 | 0.25 | Why? |
| Neutrophils | 5 | 2021 | 5476 | 0.25 | Why? |
| Italy | 17 | 2021 | 38444 | 0.24 | Why? |
| Intermediate Filaments | 1 | 2021 | 77 | 0.22 | Why? |
| Coinfection | 2 | 2020 | 6820 | 0.22 | Why? |
| Hypoparathyroidism | 1 | 2020 | 36 | 0.21 | Why? |
| tau Proteins | 1 | 2021 | 162 | 0.21 | Why? |
| Adiponectin | 1 | 2021 | 123 | 0.21 | Why? |
| Hepcidins | 1 | 2020 | 97 | 0.21 | Why? |
| Thoracic Vertebrae | 1 | 2021 | 97 | 0.21 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.20 | Why? |
| Neurofilament Proteins | 1 | 2021 | 202 | 0.20 | Why? |
| Leptin | 1 | 2021 | 141 | 0.20 | Why? |
| Gastric Mucosa | 1 | 2021 | 141 | 0.20 | Why? |
| Obesity, Abdominal | 1 | 2021 | 167 | 0.20 | Why? |
| Cytokines | 3 | 2020 | 15010 | 0.19 | Why? |
| Spinal Fractures | 1 | 2021 | 124 | 0.19 | Why? |
| Histidine-tRNA Ligase | 1 | 2018 | 4 | 0.19 | Why? |
| Qa-SNARE Proteins | 1 | 2018 | 12 | 0.19 | Why? |
| Pericardium | 1 | 2021 | 228 | 0.18 | Why? |
| Genetic Diseases, X-Linked | 1 | 2021 | 237 | 0.18 | Why? |
| Follow-Up Studies | 7 | 2021 | 17020 | 0.18 | Why? |
| Major Histocompatibility Complex | 1 | 2018 | 70 | 0.18 | Why? |
| Peritoneal Fibrosis | 1 | 2017 | 4 | 0.18 | Why? |
| Serositis | 1 | 2017 | 5 | 0.18 | Why? |
| Cathepsin D | 1 | 1997 | 8 | 0.18 | Why? |
| Intracellular Fluid | 1 | 1997 | 9 | 0.18 | Why? |
| Puerperal Disorders | 1 | 2020 | 151 | 0.18 | Why? |
| Aged | 25 | 2022 | 215776 | 0.17 | Why? |
| Sphingomyelin Phosphodiesterase | 1 | 2018 | 87 | 0.17 | Why? |
| Interferon beta-1a | 1 | 2020 | 316 | 0.17 | Why? |
| Interleukin-1 | 1 | 2021 | 438 | 0.17 | Why? |
| Female | 34 | 2022 | 380317 | 0.16 | Why? |
| Cisplatin | 1 | 2018 | 209 | 0.16 | Why? |
| Depression | 2 | 2020 | 14116 | 0.16 | Why? |
| Pregnancy Complications | 2 | 2019 | 1388 | 0.16 | Why? |
| Peritoneal Neoplasms | 1 | 2017 | 110 | 0.16 | Why? |
| Pregnancy Trimester, Third | 1 | 2018 | 445 | 0.16 | Why? |
| Homeostasis | 2 | 2017 | 582 | 0.16 | Why? |
| Tomography, X-Ray Computed | 4 | 2021 | 25144 | 0.16 | Why? |
| Wound Healing | 2 | 2017 | 424 | 0.16 | Why? |
| fas Receptor | 1 | 1996 | 85 | 0.16 | Why? |
| Prospective Studies | 11 | 2021 | 43301 | 0.16 | Why? |
| Humans | 58 | 2022 | 930598 | 0.16 | Why? |
| Hospitalization | 8 | 2021 | 54280 | 0.16 | Why? |
| Tobacco Smoking | 1 | 2020 | 349 | 0.15 | Why? |
| Pulmonary Edema | 1 | 2020 | 430 | 0.15 | Why? |
| Glioma | 1 | 2018 | 189 | 0.15 | Why? |
| Endometriosis | 1 | 2017 | 130 | 0.15 | Why? |
| Erythema | 1 | 2020 | 400 | 0.15 | Why? |
| Complement Activation | 2 | 2021 | 949 | 0.15 | Why? |
| Antigens | 1 | 1997 | 267 | 0.15 | Why? |
| Cognition Disorders | 1 | 2021 | 574 | 0.15 | Why? |
| DNA Damage | 1 | 2017 | 285 | 0.15 | Why? |
| Receptors, Interleukin-6 | 2 | 2020 | 1383 | 0.15 | Why? |
| Cell Death | 1 | 2017 | 536 | 0.14 | Why? |
| Peritonitis | 1 | 2017 | 217 | 0.14 | Why? |
| Male | 31 | 2022 | 367725 | 0.14 | Why? |
| Middle Aged | 24 | 2022 | 270681 | 0.14 | Why? |
| Overweight | 1 | 2021 | 916 | 0.14 | Why? |
| Histocompatibility Antigens Class II | 1 | 1997 | 383 | 0.14 | Why? |
| Biomarkers | 9 | 2022 | 23361 | 0.14 | Why? |
| Weight Loss | 1 | 2020 | 826 | 0.14 | Why? |
| Drug Resistance, Neoplasm | 1 | 2018 | 447 | 0.14 | Why? |
| Lysosomes | 1 | 1997 | 416 | 0.14 | Why? |
| Coronary Disease | 1 | 2020 | 645 | 0.13 | Why? |
| Mediastinal Emphysema | 1 | 2021 | 519 | 0.13 | Why? |
| Psychiatric Status Rating Scales | 1 | 2020 | 1340 | 0.13 | Why? |
| Cohort Studies | 10 | 2021 | 36005 | 0.13 | Why? |
| Pneumonia, Viral | 13 | 2020 | 243684 | 0.13 | Why? |
| Coronavirus Infections | 13 | 2020 | 253789 | 0.13 | Why? |
| Antigens, Viral | 2 | 2020 | 6298 | 0.13 | Why? |
| Autophagy | 2 | 2018 | 960 | 0.12 | Why? |
| Neoplasm Proteins | 1 | 2018 | 501 | 0.12 | Why? |
| Pneumothorax | 1 | 2021 | 758 | 0.12 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 1165 | 0.12 | Why? |
| Interleukin-6 | 2 | 2021 | 7522 | 0.12 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.12 | Why? |
| Antigens, CD | 1 | 1997 | 984 | 0.12 | Why? |
| Antiviral Agents | 4 | 2020 | 41703 | 0.11 | Why? |
| Scleroderma, Systemic | 1 | 2018 | 583 | 0.11 | Why? |
| Muscle, Skeletal | 1 | 2018 | 915 | 0.11 | Why? |
| Heparin, Low-Molecular-Weight | 2 | 2019 | 1731 | 0.11 | Why? |
| Nitric Oxide | 1 | 2018 | 769 | 0.11 | Why? |
| Depressive Disorder, Major | 1 | 2020 | 852 | 0.11 | Why? |
| Apoptosis | 3 | 2018 | 2335 | 0.11 | Why? |
| Hyperglycemia | 1 | 2022 | 1363 | 0.11 | Why? |
| Aftercare | 1 | 2020 | 1637 | 0.11 | Why? |
| Risk Factors | 9 | 2022 | 71621 | 0.10 | Why? |
| Anthropometry | 2 | 2021 | 233 | 0.10 | Why? |
| Nutritional Status | 1 | 2020 | 1403 | 0.10 | Why? |
| Hypogonadism | 2 | 2021 | 196 | 0.10 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2021 | 1545 | 0.10 | Why? |
| Oxygen Inhalation Therapy | 2 | 2020 | 3629 | 0.10 | Why? |
| Respiratory Insufficiency | 2 | 2021 | 7301 | 0.10 | Why? |
| Nucleosomes | 1 | 2008 | 48 | 0.10 | Why? |
| Immunity, Innate | 2 | 2017 | 6570 | 0.10 | Why? |
| Acute Disease | 2 | 2020 | 6029 | 0.10 | Why? |
| Pregnancy | 4 | 2019 | 23879 | 0.09 | Why? |
| Immune System Phenomena | 1 | 2008 | 35 | 0.09 | Why? |
| Dendritic Cells | 1 | 1997 | 1330 | 0.09 | Why? |
| Diabetes Complications | 1 | 2021 | 2358 | 0.09 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.09 | Why? |
| T-Lymphocyte Subsets | 1 | 1996 | 1387 | 0.09 | Why? |
| Betacoronavirus | 11 | 2020 | 204454 | 0.09 | Why? |
| Membrane Glycoproteins | 1 | 1997 | 2273 | 0.09 | Why? |
| Molecular Targeted Therapy | 1 | 2017 | 1579 | 0.09 | Why? |
| Pregnancy Outcome | 2 | 2019 | 3803 | 0.09 | Why? |
| Epitopes | 1 | 2020 | 4113 | 0.09 | Why? |
| Diabetes Mellitus | 2 | 2020 | 8207 | 0.09 | Why? |
| Vitamin D Deficiency | 1 | 2022 | 1782 | 0.09 | Why? |
| Cesarean Section | 1 | 2018 | 2089 | 0.09 | Why? |
| Mice | 6 | 2018 | 21357 | 0.09 | Why? |
| Cell Compartmentation | 2 | 1997 | 24 | 0.09 | Why? |
| Life Style | 1 | 2020 | 2708 | 0.08 | Why? |
| Anxiety Disorders | 1 | 2020 | 2290 | 0.08 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.08 | Why? |
| Adult | 14 | 2021 | 244371 | 0.08 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.08 | Why? |
| Lymphocyte Activation | 1 | 1996 | 2742 | 0.08 | Why? |
| Vitamin D | 1 | 2022 | 2904 | 0.08 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.08 | Why? |
| Risk | 1 | 2018 | 5288 | 0.08 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.07 | Why? |
| Adaptive Immunity | 1 | 2017 | 2585 | 0.07 | Why? |
| Platelet Activation | 2 | 2021 | 660 | 0.07 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.07 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.07 | Why? |
| Animals | 8 | 2018 | 78931 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Psoriasis | 1 | 2018 | 1739 | 0.07 | Why? |
| Immunity, Cellular | 1 | 2017 | 3614 | 0.07 | Why? |
| Kidney Failure, Chronic | 1 | 2020 | 3222 | 0.07 | Why? |
| Autoimmune Diseases | 1 | 2017 | 1996 | 0.07 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.06 | Why? |
| Retrospective Studies | 11 | 2022 | 105322 | 0.06 | Why? |
| Survival Analysis | 3 | 2021 | 7592 | 0.06 | Why? |
| Respiratory Tract Infections | 2 | 2020 | 6817 | 0.06 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.06 | Why? |
| Blood Glucose | 3 | 2022 | 3642 | 0.06 | Why? |
| Severity of Illness Index | 8 | 2022 | 48226 | 0.06 | Why? |
| Densitometry | 1 | 2021 | 40 | 0.06 | Why? |
| Penetrance | 1 | 2021 | 121 | 0.06 | Why? |
| Citrullination | 1 | 2021 | 85 | 0.06 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.06 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.06 | Why? |
| Pandemics | 15 | 2021 | 389249 | 0.06 | Why? |
| Dilatation, Pathologic | 1 | 2021 | 78 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.06 | Why? |
| Glial Fibrillary Acidic Protein | 1 | 2021 | 138 | 0.06 | Why? |
| Ubiquitin Thiolesterase | 1 | 2021 | 69 | 0.05 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.05 | Why? |
| Mental Disorders | 2 | 2021 | 6742 | 0.05 | Why? |
| Stomach Ulcer | 1 | 2021 | 101 | 0.05 | Why? |
| Waist Circumference | 1 | 2021 | 199 | 0.05 | Why? |
| Salivary Glands | 1 | 2021 | 122 | 0.05 | Why? |
| Pedigree | 1 | 2021 | 502 | 0.05 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.05 | Why? |
| Duodenum | 1 | 2021 | 179 | 0.05 | Why? |
| Colitis, Ischemic | 1 | 2021 | 116 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.05 | Why? |
| Abortion, Habitual | 1 | 2019 | 35 | 0.05 | Why? |
| Age Factors | 4 | 2020 | 21039 | 0.05 | Why? |
| Sex Factors | 3 | 2020 | 11014 | 0.05 | Why? |
| Mice, Knockout | 2 | 2018 | 1815 | 0.05 | Why? |
| Fluorescein-5-isothiocyanate | 1 | 1997 | 15 | 0.05 | Why? |
| Hepatitis, Viral, Animal | 1 | 2000 | 274 | 0.05 | Why? |
| Subcellular Fractions | 1 | 1997 | 25 | 0.05 | Why? |
| Injections, Subcutaneous | 1 | 2020 | 647 | 0.05 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.05 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2018 | 119 | 0.05 | Why? |
| Lysosome-Associated Membrane Glycoproteins | 1 | 1997 | 30 | 0.05 | Why? |
| Dextrans | 1 | 1997 | 35 | 0.04 | Why? |
| Lymphocyte Count | 2 | 2020 | 4758 | 0.04 | Why? |
| Gonadal Steroid Hormones | 1 | 2021 | 328 | 0.04 | Why? |
| Ovalbumin | 1 | 1997 | 84 | 0.04 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2020 | 6543 | 0.04 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.04 | Why? |
| Cytoskeleton | 1 | 1997 | 99 | 0.04 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2008 | 1380 | 0.04 | Why? |
| Receptor Aggregation | 1 | 1996 | 1 | 0.04 | Why? |
| Inositol 1,4,5-Trisphosphate | 1 | 1996 | 7 | 0.04 | Why? |
| Cell-Derived Microparticles | 1 | 2018 | 134 | 0.04 | Why? |
| Oxygen | 2 | 2020 | 3715 | 0.04 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.04 | Why? |
| Blood Proteins | 1 | 2020 | 551 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Exercise Tolerance | 1 | 2021 | 634 | 0.04 | Why? |
| Administration, Intravenous | 1 | 2020 | 1115 | 0.04 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2021 | 1654 | 0.04 | Why? |
| Clone Cells | 1 | 1996 | 312 | 0.04 | Why? |
| Fasting | 1 | 2021 | 555 | 0.04 | Why? |
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1996 | 102 | 0.04 | Why? |
| Neuropsychological Tests | 1 | 2021 | 954 | 0.04 | Why? |
| Alleles | 1 | 2021 | 1557 | 0.04 | Why? |
| Chemical and Drug Induced Liver Injury | 1 | 2000 | 451 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2017 | 540 | 0.04 | Why? |
| Iron | 1 | 2020 | 619 | 0.04 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2021 | 669 | 0.03 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.03 | Why? |
| Neurodegenerative Diseases | 1 | 2020 | 469 | 0.03 | Why? |
| Antigen Presentation | 1 | 1997 | 524 | 0.03 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Hydrogen-Ion Concentration | 1 | 1997 | 993 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.03 | Why? |
| Obsessive-Compulsive Disorder | 1 | 2020 | 486 | 0.03 | Why? |
| Infectious Disease Incubation Period | 1 | 2020 | 1033 | 0.03 | Why? |
| Continuous Positive Airway Pressure | 1 | 2021 | 1187 | 0.03 | Why? |
| Length of Stay | 2 | 2020 | 11042 | 0.03 | Why? |
| Radiography | 1 | 2020 | 1576 | 0.03 | Why? |
| Interferon-alpha | 1 | 2000 | 1442 | 0.03 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.03 | Why? |
| Stem Cells | 1 | 1997 | 595 | 0.03 | Why? |
| Emergency Service, Hospital | 3 | 2020 | 14232 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.03 | Why? |
| Suicidal Ideation | 1 | 2020 | 1226 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
| Aspirin | 1 | 2019 | 1043 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Depressive Disorder | 1 | 2020 | 1236 | 0.02 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.02 | Why? |
| Bacteremia | 1 | 2020 | 1372 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Toll-Like Receptor 9 | 1 | 2008 | 72 | 0.02 | Why? |
| Myeloid Differentiation Factor 88 | 1 | 2008 | 109 | 0.02 | Why? |
| Body Mass Index | 1 | 2022 | 4306 | 0.02 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 1692 | 0.02 | Why? |
| Cell Line | 2 | 2008 | 12040 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Receptor for Advanced Glycation End Products | 1 | 2008 | 100 | 0.02 | Why? |
| Monocytes | 1 | 2020 | 2978 | 0.02 | Why? |
| Toll-Like Receptor 2 | 1 | 2008 | 198 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Noninvasive Ventilation | 1 | 2020 | 2329 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.02 | Why? |
| Endothelium, Vascular | 1 | 2017 | 1751 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Coronary Artery Disease | 1 | 2020 | 2570 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Liver | 1 | 2000 | 4007 | 0.02 | Why? |
| Toll-Like Receptor 4 | 1 | 2008 | 390 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.02 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.02 | Why? |
| Fear | 1 | 2020 | 3607 | 0.02 | Why? |
| Cells, Cultured | 1 | 1996 | 5835 | 0.02 | Why? |
| Receptors, Immunologic | 1 | 2008 | 555 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.02 | Why? |
| Europe | 1 | 2019 | 12702 | 0.01 | Why? |
| Lung | 2 | 2021 | 31049 | 0.01 | Why? |
| Helper Viruses | 1 | 2000 | 25 | 0.01 | Why? |
| Concanavalin A | 1 | 2000 | 19 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Signal Transduction | 1 | 1996 | 7207 | 0.01 | Why? |
| Registries | 1 | 2019 | 12327 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
| Mice, Inbred BALB C | 1 | 2008 | 5814 | 0.01 | Why? |
| Infant, Newborn | 1 | 2019 | 23105 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Genetic Therapy | 1 | 2000 | 409 | 0.01 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.01 | Why? |
| Adenoviridae | 1 | 2000 | 1151 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Genetic Vectors | 1 | 2000 | 1600 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Murine hepatitis virus | 1 | 2000 | 1720 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |
| Gene Expression | 1 | 2000 | 3332 | 0.01 | Why? |
| Mice, Inbred C57BL | 1 | 2000 | 5542 | 0.01 | Why? |